Laughter therapy significantly reduces breathing difficulties in patients with chronic obstructive pulmonary disease (COPD), matching the efficacy of traditional pursed-lip breathing exercises. Presented at the European Respiratory Society Congress in Barcelona, a clinical trial demonstrated that this low-cost, accessible intervention can be practiced at home without specialized equipment.
In Plain English: The Clinical Takeaway
- What was tested: Deliberate laughter exercises (such as rhythmic clapping, playful vocalizations, and unforced laughter meditation) compared against standard pursed-lip breathing and a control group.
- The outcome: Patients performing laughter therapy experienced a measurable reduction in breathlessness and improved overall health, with benefits lasting a month after the program ended.
- Clinical application: The intervention offers a practical, low-cost adjunct therapy that patients can integrate into daily routines alongside standard medical care.
Clinical Trial Design and Patient Outcomes
Chronic obstructive pulmonary disease is a serious lung disease that makes it hard to breathe. Patients often feel breathless, even during simple daily activities, which reduces their quality of life and makes them increasingly dependent on others for care. Managing COPD requires more than medication alone; patients need a holistic approach to help them cope with their symptoms, the physical burden of the disease, and its emotional and psychological impact.
To investigate whether additional simple, low-cost techniques could complement existing care, researchers conducted a clinical trial involving 63 patients treated at Ankara Bilkent City Hospital in Türkiye. The study design randomized participants into three equal cohorts: one-third received laughter therapy, one-third were assigned to traditional pursed-lip breathing exercises, and the final third served as a control group receiving no breathing exercises. Dr. Goncagul Aldan, a lecturer and nurse graduated from Hacettepe University Faculty of Nursing, presented the findings at the European Respiratory Society Congress.
During the intervention phase, patients assigned to laughter therapy learned a structured sequence of exercises. These included rhythmic clapping paired with vocal sounds, playful simulations like mimicking a motorcycle or a lion’s roar, a laughter meditation session featuring spontaneous unforced laughter, and a concluding relaxation period focused on calm breathing and smiling. Both the laughter therapy and pursed-lip breathing groups practiced for 30 minutes, three times per week over an eight-week duration, with remote support provided via video calls and text messages.
Mechanisms of Action in Airway Clearance
Understanding why laughter therapy impacts respiratory function requires looking at the mechanics of COPD. In COPD, the airways tend to collapse during exhalation, trapping stale air inside the lungs. Traditional interventions like pursed-lip breathing create a gentle back pressure that allows this trapped air to escape.
Laughter therapy appears to engage respiratory mechanics. The active vocalization and forced exhalation inherent in deliberate laughter are part of a series of exercises designed to support respiratory health. Furthermore, the accessible and enjoyable nature of the therapy suggests it could benefit patients in coping with the daily stress of living with a chronic illness.
| Intervention Group | Core Technique | Primary Physiological Effect | Clinical Outcome |
|---|---|---|---|
| Laughter Therapy | Rhythmic vocalizations, play, and unforced laughter | Supports respiratory health and coping with daily stress | Significant reduction in breathlessness and improved overall health |
| Pursed-Lip Breathing | Inhaling via nose, slow exhalation through pursed lips | Creates gentle back pressure to expel trapped stale air | Significant reduction in breathlessness and improved overall health |
| Control Group | No breathing exercises | None | More difficulty breathing compared to treatment groups |
Global Public Health Implications and Accessibility
COPD affects millions of people worldwide and is a leading cause of disability and death.
Because laughter therapy requires no expensive equipment or specialist support, it presents a compelling model for low-resource healthcare settings. Dr. Aldan noted that the positive effects observed in the trial were sustained even one month after the formal eight-week program concluded, highlighting the durability of the intervention.
Contraindications & When to Consult a Doctor
Future Directions in Respiratory Care
As respiratory researchers continue to evaluate the long-term impacts of accessible interventions, trials like the one conducted in Ankara provide a foundation for further investigation.
References
- European Respiratory Society (ERS) Congress, Barcelona, Spain. Clinical trial presentation by Dr. Goncagul Aldan.
- Hacettepe University Faculty of Nursing, Ankara, Türkiye. Research data from Ankara Bilkent City Hospital.
Worth a look
- How to Stop Watching Short Videos All Day
- Mastering the Farmer’s Walk: The Ultimate Loaded Carry Guide
- Hope in Music: Conversations on Resilience with Eberechi Eze, Leona Lewis and Yinka Ilori | Ezra Collective” Keyword tags: – Eberechi Eze – Leona Lewis – Yinka Ilori – Ezra Collective – Conversations on Resilience – Music Therapy – Hope in Music – Resilience in the Arts – Mental Health Discussion (archyworldys.com)
- Peter and Isabel Dammann Perform Swan Songs Concert for Hospice Patients (archynewsy.com)
